| Johnson & Johnson is a holding company. Through its subsidiaries, Co. engages in the research and development, manufacture and sale of various products in the healthcare field. Co.'s segments are: Consumer Health, which includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets; Pharmaceutical, which is focused on six therapeutic areas including Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism, and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. We show 56 historical shares outstanding datapoints in our coverage of JNJ's shares outstanding history.|
Understanding the changing numbers of Johnson and Johnson shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like Johnson and Johnson versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching Johnson and Johnson by allowing them to research Johnson and Johnson shares outstanding history
as well as any other stock in our coverage universe.